Patient presents with complaints suggestive of liver metastases, possibly secondary to [Primary Cancer Site, e.g., colon cancer].  Presenting symptoms include [List symptoms, e.g., abdominal pain, fatigue, weight loss, jaundice, hepatomegaly].  Patient history includes a diagnosis of [Primary Cancer Type] in [Date of Diagnosis].  Physical examination revealed [Relevant findings, e.g., palpable liver mass, ascites, right upper quadrant tenderness].  Laboratory results show elevated [Specific liver function tests, e.g., ALP, AST, ALT, GGT] and [Other relevant markers, e.g., CEA, CA 19-9, AFP]. Imaging studies, including [Type of imaging, e.g., abdominal ultrasound, CT scan, MRI], demonstrate [Imaging findings, e.g., multiple hepatic lesions, heterogeneous enhancement].  Diagnosis of metastatic liver cancer, secondary to [Primary Cancer Site], is established based on clinical presentation, imaging findings, and laboratory results.  Differential diagnoses considered include primary liver cancer, benign liver lesions, and cirrhosis.  Treatment plan includes discussion with oncology regarding options such as systemic chemotherapy, targeted therapy, hepatic arterial infusion chemotherapy, or palliative care.  Patient education provided on disease progression, treatment options, potential side effects, and symptom management.  Referral to oncology, pain management, and palliative care as appropriate. Follow-up scheduled in [Timeframe, e.g., two weeks] to assess treatment response and address any emerging symptoms.  Prognosis discussed with the patient and family.  ICD-10 code C78.7 (Secondary malignant neoplasm of liver and intrahepatic bile ducts) and appropriate code for primary malignancy will be used for billing and coding purposes.